ADGI Annual EBIT
-$219.41 M
0.00%
31 December 2021
Summary:
As of February 5, 2025, ADGI annual earnings before interest & taxes is -$219.41 millionADGI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADGI Quarterly EBIT
-$51.75 M
+$48.99 M+48.63%
30 June 2022
Summary:
As of February 5, 2025, ADGI quarterly earnings before interest & taxes is -$51.75 million, with the most recent change of +$48.99 million (+48.63%) on June 30, 2022. Over the past year, it has dropped by -$9.56 million (-22.65%).ADGI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADGI TTM EBIT
-$292.00 M
-$9.56 M-3.38%
30 June 2022
Summary:
As of February 5, 2025, ADGI TTM earnings before interest & taxes is -$292.00 million, with the most recent change of -$9.56 million (-3.38%) on June 30, 2022. Over the past year, it has dropped by -$204.00 million (-231.84%).ADGI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADGI EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -22.6% | -231.8% |
| 3 y3 years | - | -539.4% | -3508.0% |
| 5 y5 years | - | -539.4% | -3508.0% |
ADGI EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +0.0% | +539.4% | +3508.0% |
Adagio Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$51.75 M(-48.6%) | -$292.00 M(+3.4%) |
| Mar 2022 | - | -$100.74 M(+21.2%) | -$282.44 M(+28.7%) |
| Dec 2021 | -$219.41 M | -$83.09 M(+47.3%) | -$219.41 M(+61.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$56.42 M(+33.7%) | -$136.32 M(+54.9%) |
| June 2021 | - | -$42.19 M(+11.9%) | -$87.99 M(+92.1%) |
| Mar 2021 | - | -$37.71 M(+365.9%) | -$45.80 M(+465.9%) |
| Sept 2020 | - | -$8.09 M | -$8.09 M |
FAQ
- What is Adagio Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Adagio Therapeutics?
- What is Adagio Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Adagio Therapeutics?
- What is Adagio Therapeutics quarterly EBIT year-on-year change?
- What is Adagio Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Adagio Therapeutics?
- What is Adagio Therapeutics TTM EBIT year-on-year change?
What is Adagio Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ADGI is -$219.41 M
What is the all time high annual EBIT for Adagio Therapeutics?
Adagio Therapeutics all-time high annual earnings before interest & taxes is -$219.41 M
What is Adagio Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ADGI is -$51.75 M
What is the all time high quarterly EBIT for Adagio Therapeutics?
Adagio Therapeutics all-time high quarterly earnings before interest & taxes is -$8.09 M
What is Adagio Therapeutics quarterly EBIT year-on-year change?
Over the past year, ADGI quarterly earnings before interest & taxes has changed by -$9.56 M (-22.65%)
What is Adagio Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ADGI is -$292.00 M
What is the all time high TTM EBIT for Adagio Therapeutics?
Adagio Therapeutics all-time high TTM earnings before interest & taxes is -$8.09 M
What is Adagio Therapeutics TTM EBIT year-on-year change?
Over the past year, ADGI TTM earnings before interest & taxes has changed by -$204.00 M (-231.84%)